ROYAL BANK OF CANADA - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 39 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
247
-47.7%
0.00%
Q2 2023$1,000472
+673.8%
0.00%
Q1 2023$061
+1425.0%
0.00%
Q4 2022$04
-94.8%
0.00%
Q3 2022$0
-100.0%
77
-94.0%
0.00%
Q1 2022$3,000
-88.5%
1,284
-70.4%
0.00%
Q4 2021$26,000
+4.0%
4,343
+80.1%
0.00%
Q3 2021$25,000
+257.1%
2,411
+255.1%
0.00%
Q2 2021$7,000
-36.4%
679
-7.6%
0.00%
Q1 2021$11,0007350.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders